Patrizia Nanni Selected Research

Patrizia Nanni Research Topics

Disease

52	Neoplasms (Cancer) 11/2021 - 02/2002
15	Carcinoma (Carcinomatosis) 11/2021 - 06/2003
14	Carcinogenesis 04/2019 - 02/2002
12	Neoplasm Metastasis (Metastasis) 02/2019 - 09/2006
11	Rhabdomyosarcoma 01/2021 - 07/2002
11	Breast Neoplasms (Breast Cancer) 11/2019 - 06/2004
6	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 03/2002
4	Hypoxia (Hypoxemia) 01/2021 - 10/2011
4	Osteosarcoma (Osteogenic Sarcoma) 01/2019 - 04/2006
2	Hepatitis B 01/2018 - 10/2010
2	Communicable Diseases (Infectious Diseases) 06/2015 - 10/2010
2	Neoplasm Micrometastasis 09/2010 - 02/2006
2	Sarcoma (Soft Tissue Sarcoma) 02/2010 - 03/2006
1	Noncommunicable Diseases 01/2018
1	Papilloma (Papillomatosis) 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2014
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Virus Diseases (Viral Diseases) 07/2012
1	Carcinoma in Situ 12/2011
1	Tetanus 10/2010
1	Brain Neoplasms (Brain Tumor) 06/2009

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 04/2019 - 06/2004
12	AntibodiesIBA 01/2021 - 02/2002
11	Interleukin-12 (IL 12)IBA 01/2018 - 02/2002
6	Biological ProductsIBA 11/2019 - 11/2009
6	Monoclonal AntibodiesIBA 01/2018 - 07/2002
5	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 02/2005
5	Insulin-Like PeptidesIBA 04/2019 - 09/2006
5	Proteins (Proteins, Gene)FDA Link 01/2014 - 07/2002
5	AntigensIBA 01/2013 - 06/2004
5	CytokinesIBA 07/2011 - 06/2004
4	Trastuzumab (Herceptin)FDA Link 01/2019 - 05/2014
4	Oncogene Proteins (Oncogene Protein)IBA 08/2017 - 11/2004
4	Cancer VaccinesIBA 05/2014 - 11/2007
4	Interferon-gamma (Interferon, gamma)IBA 03/2009 - 06/2003
3	human ERBB2 proteinIBA 04/2019 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2006
3	Epidermal Growth Factor (EGF)IBA 01/2018 - 07/2002
3	Mitochondrial DNA (mtDNA)IBA 03/2014 - 10/2011
3	Tamoxifen FDA LinkGeneric 12/2011 - 06/2003
3	Myosins (Myosin)IBA 04/2009 - 06/2003
2	EnzymesIBA 01/2021 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
2	Neutralizing AntibodiesIBA 02/2019 - 03/2002
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2007
2	Caveolin 1IBA 01/2019 - 04/2006
2	CarcinogensIBA 01/2018 - 02/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017 - 09/2006
2	Protein Isoforms (Isoforms)IBA 08/2017 - 11/2014
2	Interleukin-15 (Interleukin 15)IBA 05/2015 - 06/2004
2	ErbB-2 ReceptorIBA 05/2014 - 11/2010
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 03/2014 - 03/2013
2	DNA VaccinesIBA 01/2014 - 12/2013
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014 - 07/2011
2	LigandsIBA 07/2012 - 08/2007
2	InterleukinsIBA 11/2007 - 06/2004
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2007 - 03/2002
2	Connective Tissue Growth FactorIBA 01/2007 - 03/2004
1	ClaudinsIBA 11/2021
1	Sunitinib (Sutent)FDA Link 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 04/2019
1	Phosphotransferases (Kinase)IBA 04/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	MC3343IBA 01/2018
1	quinolineIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	PerforinIBA 05/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	AgarIBA 03/2013
1	pimonidazoleIBA 03/2013
1	Genetic Markers (Genetic Marker)IBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 07/2012
1	Acyclovir (Aciclovir)FDA LinkGeneric 07/2012
1	NVP-BKM120IBA 01/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2011
1	Succinic Acid (Succinate)IBA 10/2011
1	DeoxyribonucleotidesIBA 07/2011
1	ProteomeIBA 11/2010
1	AutoantibodiesIBA 11/2010
1	Viral VaccinesIBA 09/2010
1	dactolisibIBA 02/2010

Therapy/Procedure

15	Therapeutics 01/2021 - 07/2002
6	Immunotherapy 01/2018 - 02/2005
2	Aftercare (After-Treatment) 01/2021 - 02/2007
1	Intravenous Injections 02/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Tertiary Prevention 06/2015
1	Chemoprevention 12/2011
1	Oncolytic Virotherapy 06/2009